TransCode Therapeutics 株価情報 (NASDAQ: RNAZ)

最新ニュース TransCode Therapeutics (NASDAQ:RNAZ) 株価情報

TransCode Therapeutics

TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics Inc

BMO Capital analyst Jack Matten maintains Equitable Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQH#NYSE">EQH</a>) with a Outperform and raises the price target from $69 to $72.

News

Price Target

Analyst Ratings

BMO Capital Maintains Outperform on Equitable Hldgs, Raises Price Target to $72

WIIM

SBAC

SBA Communications shares are trading higher after the company reported better-than-expected Q4 revenue results.

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/02/2025-02-25_08h21_50.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">Hopium Meeting Reality</h4>
Please <a href="https://thearorareport.com/chart-analysis-stock-market-nvidia-earnings-ahead-china-cut-cable-hims-mc-02252025">click here</a> for an enlarged chart of Hims &amp; Hers Health Inc (HIMS).
Note the following:
<ul>
<li>In many areas, hopium from President Trump is justified.&nbsp; However, the momo crowd has taken it to an extreme.&nbsp; As an example, to the best of our knowledge, President Trump has not made a vigorous public statement saying that he would allow copycat versions of weight loss drugs by changing the current law.&nbsp; Yet, the momo crowd, with its absolute faith in President Trump, continued to buy HIMS stock believing President Trump would be their savior.</li>
<li>This article is about the big picture, not an individual stock.&nbsp; The chart of HIMS is being used to illustrate the point.&nbsp; HIMS is a telehealth company that has grown rapidly by selling copycat weight loss drugs.&nbsp; The law allows compounded versions when there is a shortage.</li>
<li>The chart shows the momo crowd was aggressively running up HIMS stock when the FDA posted on its website that the Wegovy and Ozempic shortage had ended.  Wegovy and Ozempic are weight loss drugs from Novo Nordisk A/S (NVO).  Semaglutide is the active ingredient of these drugs.  HIMS has been selling a copycat version of semaglutide.</li>
<li>It was well known that the Wegovy and Ozempic shortage was going to end in February.&nbsp; Yet, the momo crowd continued to buy HIMS stock on the belief that President Trump would bar the FDA from enforcing the law.</li>
<li>Previously, a shortage of Eli Lilly And Co (LLY) weight loss drug Zepbound with active ingredient tirzepatide had ended.  HIMS was involved in compounding tirzepatide.  At that time, HIMS stock was trading much lower than where it has been trading recently.  HIMS stock initially dropped, and the momo crowd aggressively bought the dip.  HIMS mainstay was semaglutide, and not tirzepatide.  The momo crowd continued to run up HIMS stock on hopium that by the time the Wegovy and Ozempic shortage ended, President Trump would be in office and would save them.</li>
<li>The chart shows the drop in HIMS stock even though the FDA said it was not taking any action against compounders for violations.</li>
<li>The chart shows another big drop on earnings after the market closed yesterday, even though earnings were good.&nbsp; The reason the stock dropped is HIMS said it would stop selling the compounded version of semaglutide.</li>
<li>Prudent investors should note the drop in HIMS stock in a short time from about $72 to $40.44 as of this writing in the premarket when unrealistic Trump hopium did not come through.  Many stocks have been run up on unrealistic Trump hopium.  Some stocks are beginning to see a selloff.  Examples include Palantir Technologies Inc (PLTR), MicroStrategy Inc (MSTR), Coinbase Global Inc (COIN), Robinhood Markets Inc (HOOD), Oklo Inc (OKLO), and Carvana Co (CVNA).</li>
<li>In The Arora Report analysis, the stock market is beginning to realize that the momo crowd buying on President Trump hopium has been excessive.</li>
<li>Adding to the stock market's anxiety this morning, the Trump administration is working on tougher restrictions of U.S. semiconductors.  The aim is for allies to apply the same pressure towards China.  Trump's team met with Dutch and Japanese counterparts regarding restricting ASML Holding NV (ASML) and Tokyo Electron ADR (TOELY) maintenance of semiconductor equipment in China.   Similar restrictions are in place for American chip companies, including Applied Materials Inc (AMAT) and Lam Research Corp (LRCX).</li>
<li>Also adding to the anxiety are investors waking up to Taiwan's vulnerability.&nbsp; Please see the section below.</li>
<li>Consumer confidence was released at 10am ET and may be market moving.</li>
<li>Nvidia (NVDA) will report earnings after the close tomorrow.&nbsp; All eyes are on NVDA as these earnings may be a make or break moment for the stock market.</li>
</ul>
<h4 class="wp-block-heading">Chinese Ship Caught</h4>
Taiwan is very dependent on undersea cables for the internet and communications.&nbsp; A Chinese ship has been caught cutting an undersea cable.&nbsp; As we have previously shared, in the event of China invading Taiwan, the first action from China will likely be cutting undersea cables.
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are positive in NVIDIA Corp (NVDA). In the early trade, money flows are neutral in Apple Inc (AAPL), Amazon.com, Inc. (AMZN), and Meta Platforms Inc (META).
In the early trade, money flows are negative in Alphabet Inc Class C (GOOG), Microsoft Corp (MSFT), and Tesla Inc (TSLA).
In the early trade, money flows are neutral in SPDR S&amp;P 500 ETF Trust (SPY) and Invesco QQQ Trust Series 1 (QQQ).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (SLV).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Whales from Asia appear to be selling Bitcoin to mom and pop in the U.S.  Whales' selling is causing bitcoin to drop below $90,000.
<h4 class="wp-block-heading">Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.&nbsp; The proprietary protection band from The Arora Report is very popular.&nbsp; The protection band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Market Summary

Markets

Momo Stocks Sell Off As Trump Hopium Meets Reality, All Eyes On Nvidia, China Caught Cutting Cable

Trading Ideas

Novartis Shares Fall After Reuters Reports Block Trade

On Tuesday,&nbsp;Henry Schein Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSIC#NYSE">HSIC</a>) reported a fourth-quarter adjusted EPS of $1.19, up 80.3% year-over-year,&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">missing the consensus of $1.21</a>.
Sales were $3.19 billion, an increase of 5.8%, missing&nbsp;the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43934994/henry-schein-reports-fourth-quarter-and-full-year-2024-financial-results-and-provides-detailed-202" rel="noreferrer noopener">consensus of $3.30 billion</a>.
Sales growth reflects 5.5% internal sales growth, 0.7% sales growth from acquisitions, and a 0.4% sales decrease resulting from foreign currency exchange. Excluding the impact of personal protective equipment (PPE) and COVID test kits, internal sales growth was 6.6%.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42470172/what-does-dental-player-pattersons-41-billion-deal-mean-for-other-players-analyst-outlines" rel="noreferrer noopener">What Does Dental Player Patterson&#8217;s $4.1 Billion Deal Mean For Other Players?</a>
"Our fourth quarter financial results reflect relatively stable dental and medical end-markets. We continued to make progress on our 2022 to 2024 BOLD+1 Strategic Plan which we recently completed, exceeding our 2024 target of generating 40% of our worldwide operating income from high-growth, high-margin businesses," said Stanley Bergman, chairman and CEO of Henry Schein.
As part of the new strategy, the company has restructured its organization into three segments:
<ul>
<li>Global Distribution and Value-Added Services ($10.8 billion in sales)</li>
<li>Global Specialty Products ($1.4 billion in sales)</li>
<li>Global Technology ($630 million in sales)</li>
</ul>
According to William Blair, it is &#8220;difficult to get an initial read on which segments underperformed.&#8221;
The firm&#8217;s analysts assume continued weakness in dental end-markets weighed on the dental segment, &#8220;especially for equipment and to some degree maybe even merchandise.&#8221;
Guidance: Henry Schein forecasts 2025 adjusted EPS of $4.80-$4.94 versus a consensus of $5.01. The company also expects sales growth of approximately 2%-4% over 2024.
Analyst Brandon Vazquez notes that the company&#8217;s 2025 outlook is slightly below Wall Street expectations, likely due to stable but weak market demand and spending on future growth, such as a new e-commerce site, which could temporarily impact profit margins.
Price Action:&nbsp;At last check on Tuesday, HSIC stock was down 3.91% at $74.61.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/buybacks/25/02/43940680/trip-com-shares-drop-despite-strong-q4-earnings-and-record-travel-demand-details" target="_blank" rel="noreferrer noopener">Trip.com Shares Drop Despite Strong Q4 Earnings and Record Travel Demand: Details</a></li>
</ul>
Image: Shutterstock

Analyst Color

Earnings

Large Cap

Guidance

Health Care

Movers

General

HSIC

Henry Schein Q4 Earnings And Outlook Miss Expectations, Restructures For Growth

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) with a Buy and maintains $31 price target.

Reiteration

CLNN

HC Wainwright & Co. Reiterates Buy on Clene, Maintains $31 Price Target

Shares of Riot Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) tanked in early trading on Tuesday, despite the company reporting <a href="https://www.benzinga.com/news/earnings/25/02/43928216/riot-platforms-shares-climb-after-fy-2024-results-details">a revenue beat for fiscal 2024</a>.
Although the company reported record revenues and profits as well as improving mining efficiency for the fourth quarter, its operating costs came in higher than its guidance, according to JPMorgan.
The Riot Platforms Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/611bba00b4035700018b67b6/reginald-smith">Analyst Reginald Smith</a> maintained an Overweight rating on the stock.
The Riot Platforms Thesis: Management highlighted the HPC (high-performance computing) opportunity of their Texas sites, indicating "scale and proximity to major metro areas," Smith said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
"Riot is seeing interest from hyperscalers and large AI companies, but did not report any material updates," he added.
The company announced the acquisition of electrical engineering service provider E4A Solutions for $52 million, which is planned to become part of its Engineering Arm, the analyst stated.
"Operationally, Riot is showing promising improvement, both in terms of mining uptime and progress towards signing an HPC deal, but operating expenses continue to run high," Smith further wrote.
RIOT Price Action: Shares of Riot Platformshad declined by12.23% to $8.77 at the time of publication on Tuesday.
Read More: <a href="https://www.benzinga.com/25/02/43931639/riot-platforms-ceo-reaffirms-plan-to-boost-bitcoin-yield-but-not-looking-too-closely-at-strategys-maneuvers">&nbsp;Riot Platforms CEO Reaffirms Plan To Boost Bitcoin Yield But &#8216;Not Looking Too Closely&#8217; At Michael Saylor-Led Strategy&#8217;s Maneuvers</a>
Photo: Shutterstock

Earnings Beats

RIOT

Riot Platforms Posts Record Q4: Analyst Concerned About Operating Costs, Lack Of Details

Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) shares are moving lower on Tuesday after the company reported earnings for the 2024 fiscal-year fourth-quarter and issued <a href="https://www.benzinga.com//node/43927381">guidance below estimates</a>.
What To Know: Chegg expects first-quarter sales of $114.00 million to $116.00 million, versus analysts&#8217; estimate of $138.07 million.
The company also guided subscription services revenue from $104.00 million to $106.00 million, gross margin between 66% and 67% and adjusted EBITDA in the range of $13.00 million to $14.00 million.
Nathan Schultz, CEO and President of Chegg, attributed the lower-than-expected guidance to industry-wide challenges. He said that the rise of Google AIO has significantly impacted Chegg's traffic and revenue, as Google AIO displays AI-generated content from third-party sources like Chegg, keeping traffic on Google's platform.
Schultz stated that Google AIO has caused non-subscriber traffic to drop 49% in January 2025, down significantly from the 8% decrease in the 2024 fiscal-year second-quarter. Notably, Chegg is currently suing Google over the issue.
&#8220;While the challenges we outlined will persist, we are focused on the clear goal of stabilizing the business through the course of 2025. We are driven by a core belief that the relevancy and need for comprehensive student success platforms – offering an adaptive, personalized experience to support learning – will only increase over the coming years,&#8221; said Schultz.
Related Link: <a href="https://www.benzinga.com/insights/news/25/02/43942414/board-member-of-hackett-group-sold-94k-in-stock">Board Member Of Hackett Group Sold $94K In Stock</a>
CHGG Price Action: At the time of writing, Chegg stock is trading 28.9% lower at $1.10, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

CHGG

What's Going On With Chegg Shares Tuesday?

BMGL

Trading Halt: Halt status updated at 11:50:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

<ul>
<li>In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and specificity of conventional radiography.</li>
<li>In addition, can&nbsp;improve cast and metal imaging,&nbsp;eliminate the need for CT in some cases while at the same time reducing the patient radiation exposure and radiologist reading time.
<ul>
<li>The Nanox.ARC outperformed standard x-ray in detecting lung nodules under simulated obesity conditions in phantoms</li>
</ul>
</li>
</ul>

Biotech

Events

NNOX

Nanox To Present New Clinical Data On Nanox.ARC At ECR 2025

HC Wainwright &amp; Co. analyst Joseph Pantginis maintains Nuvectis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCT#NASDAQ">NVCT</a>) with a Buy and lowers the price target from $21 to $11.

NVCT

HC Wainwright & Co. Maintains Buy on Nuvectis Pharma, Lowers Price Target to $11

<a href="https://www.grifols.com/en/view-news/-/news/thomas-glanzmann-to-retire-as-grifols-chairman-and-will-be-succeeded-by-board-member-anne-catherine-berner" title="https://www.grifols.com/en/view-news/-/news/thomas-glanzmann-to-retire-as-grifols-chairman-and-will-be-succeeded-by-board-member-anne-catherine-berner">https://www.grifols.com/en/view-news/-/news/thomas-glanzmann-to-retire-as-grifols-chairman-and-will-be-succeeded-by-board-member-anne-catherine-berner</a>

Management

GRFS

Grifols Chairman Thomas Glanzmann To Retire; To Be Succeeded Ann-Catherine Berner

<a href="https://central.virtualshareholdermeeting.com/vsm/web?pvskey=AAPL2025" title="https://central.virtualshareholdermeeting.com/vsm/web?pvskey=AAPL2025">https://central.virtualshareholdermeeting.com/vsm/web?pvskey=AAPL2025</a>

AAPL

CEO Tim Cook Says As Legal Landscape Around Diversity Changes, Apple May Have To Make Changes To Comply

Apple Will Be Largest Customer Of Taiwan Semiconductor Manufacturing's Arizona Factory

TD Securities analyst Andrew Charles reiterates Restaurant Brands Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QSR#NYSE">QSR</a>) with a Hold and maintains $70 price target.

TD Securities Reiterates Hold on Restaurant Brands Intl, Maintains $70 Price Target

A recent call to Dave Ramsey&#8217;s <a href="https://www.youtube.com/watch?v=xz5rJziEDn0">show</a> left the financial guru shocked when a caller revealed that, despite earning between $500,000 and $600,000 a year, he and his wife were barely saving anything as their monthly expenses are a staggering $30,000.
<h2 class="wp-block-heading">A High Income, But No Savings</h2>
The caller, who owns a service-based business while his wife earns $100,000 at her job, admitted that taxes and expenses leave them with almost nothing left over. Ramsey immediately pointed out the glaring issue: &#8220;I think the $30,000 a month expense is your clue.&#8221; But how much of that is debt payments?
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/suze-orman-retirement-bucket">&#8216;Which Bucket Do I Draw From First?&#8217; Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts</a></li>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
</ul>
The caller explained that $12,000 went toward <a href="https://www.benzinga.com/personal-finance/24/06/39169280/dave-ramsey-says-smart-people-dont-take-out-30-year-mortgages-if-you-cant-afford-a-home-on-a-15-">mortgage payments</a> on their primary residence and an investment property. The rest was spent on charity ($8,000 to $9,000 a month) and household expenses like groceries, utilities, and car payments.
That's when Ramsey dropped the question that summed up his disbelief: &#8220;Why do you need $18,000 a month to run your household?&#8221; He was especially puzzled by their <a href="https://www.benzinga.com/24/11/42122576/dave-ramsey-guarantees-if-you-have-a-car-payment-you-will-be-broke-your-whole-life-heres-how-he-says-you-can-become-rich">car expenses</a>. &#8220;Why would you have a car payment when you make $600,000 a year?&#8221; he asked, criticizing their <a href="https://www.benzinga.com/personal-finance/25/01/43039835/dave-ramsey-breaks-down-how-a-40000-car-depreciates-by-16000-over-5-years-says-its-not-a-path-to-prosperity-even-on-an-80000-salary">decision to lease a car</a> for $750 a month instead of buying it outright.
Trending: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a>
Ramsey emphasized that the couple's problem wasn't income—it was their lack of financial control. &#8220;If I woke up in your shoes, you've got a level of disgust that says this is not okay. We make this kind of money; we shouldn't have no money.&#8221; He compared their situation with running a business poorly. &#8220;If you had a person working in your business managing a section of it as poorly as you are managing your finances, you would fire them for incompetence.&#8221;
His advice? They need to start budgeting intentionally. &#8220;Do a detailed budget with your spouse and come into agreement on what we want to give, what we want to save, and what we want to spend,&#8221; Ramsey advised. He stressed that every dollar should have an assignment before the month begins.
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Ramsey also suggested they reconsider their heavy charitable giving—at least temporarily—if they're doing zero investing. &#8220;Generosity is awesome, investing is amazing, enjoying money—yes! You should do all three things. But very, very, very, very, very intentional. And right now, you&#8217;re not intentional.&#8221;
It&#8217;s obvious that this couple isn't broke because they don't make enough money. They're broke because they aren't managing it properly. &#8220;You're just throwing a bale of dollars over the fence and then coming back to see what's left later.&#8221;
Read Next:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
</ul>

Personal Finance

Dave Ramsey Baffled By Family Living Paycheck-To-Paycheck On $600,000 A Year—'Why Do You Need $18,000 A Month To Run Your Household?'

In the current market session, Vulcan Materials Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMC#NYSE">VMC</a>) price is at $252.12, after a 0.22% spike. However, over the past month, the stock fell by 9.49%, and in the past year, by 5.07%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1740501917_0.png" alt="Past Year Chart" />

<h3>How Does Vulcan Materials P/E Compare to Other Companies?</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Vulcan Materials has a better P/E ratio of 36.41 than the aggregate P/E ratio of 18.19 of the Construction Materials industry. Ideally, one might believe that Vulcan Materials Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1740501917_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Price Over Earnings Overview: Vulcan Materials

Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) has outperformed the market over the past 10 years by 3.99% on an annualized basis producing an average annual return of 14.88%. Currently, Sprouts Farmers Market has a market capitalization of $14.22 billion. 
Buying $1000 In SFM: If an investor had bought $1000 of SFM stock 10 years ago, it would be worth $3,927.06 today based on a price of $144.29 for SFM at the time of writing.
<h3>Sprouts Farmers Market's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740501910_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

Goldman Sachs analyst Brian Lee shared key takeaways from investor meetings with<a target="_blank" href="https://www.benzinga.com/quote/SEDG/analyst-ratings" rel="noreferrer noopener"> </a><a target="_blank" href="https://www.benzinga.com/quote/SEDG/analyst-ratings" rel="noreferrer noopener">SolarEdge Technologies, Inc. </a><a target="_blank" href="https://www.benzinga.com/quote/SEDG/analyst-ratings" rel="noreferrer noopener">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>)</a>.
Lee, who retained a Buy rating with a price target of $31, expects domestic content and TPO market exposure to drive market share gains. He also says the company&#8217;s MLPE solution is the best way to maximize domestic content.
Despite lower US sales in fourth quarter of 2024, favorable trends should support demand growth, he added.
With full domestic manufacturing capacity, SEDG plans to ship products to Europe starting in 2026 for margin improvement.
Management is confident that European channel inventories will normalize by the end of the second quarter of 2025.
The company also expects to benefit from 45X credits through new C&amp;I inverter production and sees its safe harbor deals as less risky than competitors&#8217; near-term deals, adds the analyst.
Lee says that with domestic manufacturing for residential and C&amp;I now complete, SEDG aims to generate cash flows and benefit from IRA credits.
SolarEdge should also pay down convertible notes later this year while maintaining over $400 million in cash on its balance sheet. It had around $700 million at the end of 2024, Lee said.
Management plans to reduce fixed costs within cost of goods sold and lower operating expenses to $85 million-$95 million by year-end, with further reductions next year, adds the analyst.
The analyst writes that SEDG expects above-normal seasonal growth in 2025 due to factors like normalizing channel inventories, price reductions, <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">domestic content, and safe harboring</a>.
Typical seasonality includes: 
<ul>
<li>+5% shift in first-quarter</li>
<li>+20% in second-quarter </li>
<li>+5% in third quarter, and </li>
<li>-15% in fourth-quarter.</li>
</ul>
Safe harboring could boost the second-quarter uplift, adds the analyst.
Despite weak European demand and price cuts, management expects a 10% YoY price drop, considering US price increases and greater US weighting.
Last week, SolarEdge reported fourth-quarter results. Revenues of $196.2 million beat the consensus of $188.704 million. The adjusted loss per share of $3.52 missed <a href="https://www.benzinga.com/25/02/43811938/solaredge-q4-revenue-beats-losses-shrink-is-a-turnaround-ahead" target="_blank" rel="noreferrer noopener">the street view for a loss of $1.65</a>.
Investors can gain exposure to the stock via two ETFs: 
ProShares S&amp;P Kensho Cleantech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTEX#NYSE">CTEX</a>) and SPDR S&amp;P Kensho Clean Power ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNRG#NYSE">CNRG</a>).
Price Action: SEDG shares are down 0.49% at $18.37 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/02/43821214/trump-calls-for-more-tariffs-federal-reserve-minutes-on-deck-whats-driving-markets-wednesday" target="_blank" rel="noreferrer noopener">Trump Calls For More Tariffs, Federal Reserve Minutes On Deck: What&#8217;s Driving Markets Wednesday?</a></li>
</ul>
Image: Shutterstock

CNRG

CTEX

SEDG

Goldman Sachs Analyst Optimistic On SolarEdge's Strong Domestic Manufacturing, European Expansion

BMO Capital analyst Andrew Strelzik maintains Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) with a Outperform and raises the price target from $500 to $515.

BMO Capital Maintains Outperform on Domino's Pizza, Raises Price Target to $515

Press Releases

TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance

TransCode Therapeutics Open Letter to Shareholders

TransCode Therapeutics Announces 1-for-33 Reverse Stock Split

Financing

TransCode Therapeutics, Inc. Announces $8 Million Private Placement

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial

Comments

TransCode Therapeutics

ニュース

最新ニュース TransCode Therapeutics (NASDAQ:RNAZ) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル